Skip to content

EVALUER L'IMPACT PREDICTIF DU SCORE MEESSI POUR LA STRATIFICATION DU RISQUE DES PATIENTS ADMIS POUR INSUFFISANCE CARDIAQUE AIGUE DANS LES STRUCTURES D'URGENCES

EVALUER L'IMPACT PREDICTIF DU SCORE MEESSI POUR LA STRATIFICATION DU RISQUE DES PATIENTS ADMIS POUR INSUFFISANCE CARDIAQUE AIGUE DANS LES STRUCTURES D'URGENCES (ICA-MEESSI)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04417881
Acronym
ICA-MEESSI
Enrollment
367
Registered
2020-06-05
Start date
2020-12-19
Completion date
2021-06-23
Last updated
2021-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acurate Heart Failure

Keywords

caring, emergency

Brief summary

Our primary purpose is to assess MEESSI score in predicting mortality and readmission of patients managed for acute heart failure (AHF) in Emergency Department. European Society of Cardiology recommend risk stratification for patients with AHF. MEESSI score is not prospectively validated out of Spain.

Interventions

MEESSI score in predicting mortality and readmission of patients managed for acute heart failure (AHF) in Emergency Department.

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major patient * Patient admitted to emergencies with suspicion of ICA according to the clinical intuition of the emergency doctor after interrogation, clinical examination, biology and imaging * Patient with health insurance * Subject who accept to participate in the research

Exclusion criteria

* Patient who refuse to participate in the study * Patient with coronary syndrome with ST segment elevation * Other diagnosis of dyspnea * Persons deprived of their freedom or under the protection of justice * Persons under guardianship or curatorship * Impossibility of giving the patient informed information * Pregnant woman

Design outcomes

Primary

MeasureTime frameDescription
MEESSI score30 daysTscore to predict the patient's future in the month following management for ED ICA. That is to say the number of days alive outside the hospital in the month following an ICA episode.

Secondary

MeasureTime frameDescription
Re-admission rate30 days30-day re-admission rate compared between the 4 risk categories defined by the MEESSI score
Mortality rate30 daysMortality rate at 30 days compared between the 4 risk categories defined by the MEESSI score
Sensitivity30 daysSensitivity, specificity and ROC curve of the MEESSI score in relation to the composite criterion according to the 4 risk categories

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026